Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Nathan

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Nature Communications|February 19, 2021
Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosisMatthew F Wipperman, Shakti K Bhattarai, Charles Kyriakos Vorkas, et al.
Cell Host & Microbe|March 11, 2008
Selective killing of nonreplicating mycobacteriaRuslana Bryk, Benjamin Gold, Aditya Venugopal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2025
Candidate transmission survival genome of <i>Mycobacterium tuberculosis</i>Saurabh Mishra, Prabhat Ranjan Singh, Xiaoyi Hu, et al.
Frontiers in Microbiology|July 14, 2020
Activity-Based Protein Profiling Reveals That Cephalosporins Selectively Active on Non-replicating <i>Mycobacterium tuberculosis</i> Bind Multiple Protein Families and Spare Peptidoglycan TranspeptidasesLandys Lopez Quezada, Robert Smith, Tania J Lupoli, et al.
Journal of Medicinal Chemistry|May 5, 2016
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosisBen Gold, Robert Smith, Quyen Nguyen, et al.
Plos Pathogens|June 24, 2020
Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EBRuslana Bryk, Shashirekha Mundhra, Xiuju Jiang, et al.
ACS Infectious Diseases|February 2, 2021
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding InteractionsJohn Ginn, Xiuju Jiang, Shan Sun, et al.
ACS Infectious Diseases|September 14, 2016
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosisThulasi Warrier, Maria Martinez-Hoyos, Manuel Marin-Amieva, et al.
Mbio|July 11, 2019
Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorALandys Lopez Quezada, Sandra Silve, Mark Kelinske, et al.
EMBO Molecular Medicine|April 7, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationDirk Schnappinger, Steven J Berthel, Helena I M Boshoff, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Nature Communications|February 19, 2021
Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosisMatthew F Wipperman, Shakti K Bhattarai, Charles Kyriakos Vorkas, et al.
Cell Host & Microbe|March 11, 2008
Selective killing of nonreplicating mycobacteriaRuslana Bryk, Benjamin Gold, Aditya Venugopal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2025
Candidate transmission survival genome of <i>Mycobacterium tuberculosis</i>Saurabh Mishra, Prabhat Ranjan Singh, Xiaoyi Hu, et al.
Frontiers in Microbiology|July 14, 2020
Activity-Based Protein Profiling Reveals That Cephalosporins Selectively Active on Non-replicating <i>Mycobacterium tuberculosis</i> Bind Multiple Protein Families and Spare Peptidoglycan TranspeptidasesLandys Lopez Quezada, Robert Smith, Tania J Lupoli, et al.
Journal of Medicinal Chemistry|May 5, 2016
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosisBen Gold, Robert Smith, Quyen Nguyen, et al.
Plos Pathogens|June 24, 2020
Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EBRuslana Bryk, Shashirekha Mundhra, Xiuju Jiang, et al.
ACS Infectious Diseases|February 2, 2021
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding InteractionsJohn Ginn, Xiuju Jiang, Shan Sun, et al.
ACS Infectious Diseases|September 14, 2016
Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosisThulasi Warrier, Maria Martinez-Hoyos, Manuel Marin-Amieva, et al.
Mbio|July 11, 2019
Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorALandys Lopez Quezada, Sandra Silve, Mark Kelinske, et al.
EMBO Molecular Medicine|April 7, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationDirk Schnappinger, Steven J Berthel, Helena I M Boshoff, et al.
Pageof 13